Evora Biosciences-preview

Evorabio

Evora Biosciences

Private

Illkirch-GraffenstadenHealthcare & Life Scienceshttps://www.evorabio.com/

Last Round

Grant

Dec 6, 2021

Total Funding Raised

$939,000

Momentum Score

50 /100

Company Overview

Evora Biosciences is a biotechnology company that develops novel immunomodulatory lipopeptides and exosome-based therapies for autoimmune and inflammatory diseases.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery, Clinical Trials

Business Model

B2B

Customer Profile

Revenue Share, Government Contracts

AI Layer

Non-AI

Keywords

immunomodulatory lipopeptidessteroid-sparing therapyautoimmune disease therapyinflammatory disease therapyexosome therapylipopeptide therapeuticsregenerative medicinepreclinical biotechgastrointestinal fistula treatmentoff-the-shelf therapyallogeneic therapydermatology therapeuticsophthalmology therapeuticsdrug discovery

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Evora Biosciences Comps

Public and private peers based on sector, stage, and business model.

Company	Status	Est. Valuation	Rev Multiple
OpenAI	Private	$86.0B	~40x
Cohere	Private	$5.0B	--
Competitor 1	Public	$XX.XB	XXx
Competitor 2	Public	$XX.XB	XXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

Evora Biosciences Funding Rounds

Historical fundraising activity

Round	Date	Amount Raised	Valuation	Investors	Sources
Grant	Dec 6, 2021
Grant	Jul 8, 2021
Grant	Jun 3, 2020

View all Funding Rounds

Key People

Founding team and executive leadership

Hadrien Lanvin

Founder CEO

Founding Team

Evora Biosciences Investors

Notable investors and investment history

Investor	Rounds
WeLikeStartup	Angel
Bpifrance	Grant
EIT Health	Grant
Wilco	Angel, Accelerator
Erganeo	Angel
Investessor	Angel

View all Investors

Market signals

Structured signals derived from secondary market and firmographic data.

Apr 19, 2026
Monthly visitors increased 79% MoM.
Dec 8, 2025
Monthly visitors grew 105% MoM, reaching 1K.

View all signals

Evora Biosciences Filings

SEC and related filings with document metadata.

Typed	Date	Amount Offered	Amount Sold	Filling	Pages	Download
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation

Evora Biosciences Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Evora Biosciences's valuation, stock price, and market status.

Firmographic Details

HeadquartersIllkirch-Graffenstaden

Employee Range5

Year Founded2020

Last FundingDec 6, 2021

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.